Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis
Clinical trial NCT02780323 · COMPLETED
Trial details
- NCT number
- NCT02780323
- Sponsor
- Dong-A ST Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-02
- Primary completion
- 2017-12-26
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.